Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV

Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum

Rolf Mentlein, Baptist Gallwitz, Wolfgang E. Schmidt · European Journal of Biochemistry · 1993 · 1.2K citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Timothy J. Kieffer, Christopher H.S. McIntosh, Raymond A. Pederson · Endocrinology · 1995 · 1.1K citations

Life Sciences, Biochemistry, Endocrinology +17

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

Daniel J. Drucker, Porat M. Erlich, Patricia L. Brubaker · Proceedings of the National Academy of Sciences · 1996 · 875 citations

Life Sciences, Cell Biology, Endocrinology +16

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.

Carolyn F. Deacon, Anders H. Johnsen, Jens J. Holst · The Journal of Clinical Endocrinology & Metabolism · 1995 · 757 citations

Life Sciences, Biochemistry, Endocrinology +16

Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function

Michael Gleeson, S.R. Bloom, J. M. Polak et al. · Gut · 1971 · 382 citations · Full text

Medicine, Endocrinology, Oncology +16